Hashimoto et al. showed that programmed death-ligand 1 (PD-L1) expression on the surface of pancreatic cancer cells was significantly reduced after silencing ARF6 and ASAP1 (17). This evidence concerns the gene ASAP1 and pancreatic neoplasm.